---

---

conference   tags : Cancer   

save search

---

NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
NSTG M | $0.1053 -37.43% -0.19% 0 |

Health Technology

| Email alert Add to watchlist
conference association cancer research

---

BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
Published: 2024-04-03 (Crawled : 11:00) - prnewswire.com
TECH | $64.115 2.09% 500K |

Health Technology

| -8.67% | O: -0.68% H: 0.7% C: -0.62%
conference association cancer research

---

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
PSTV | News | $1.67 0.6% 13K |

Health Technology

| -10.75% | O: -2.69% H: 3.31% C: 3.31%
conference cancer network therapeutics plus

---

Angle PLC Announces Parsortix at European Breast Cancer Conference
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
ANPCF | News | $0.148 641.22% 5K |

Health Technology

| Email alert Add to watchlist
ANPCY | News | $1.98 338.38% 930 |

Manufacturing

| Email alert Add to watchlist
conference breast cancer

---

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
Published: 2024-03-06 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K |

Professional, Scientific, and T...

| -18.82% | O: 0.0% H: 3.79% C: -8.24%
conference breast cancer system

---

Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
LIXT | $3.35 8.6K |

Health Technology

| 51.58% | O: 3.17% H: 23.6% C: 17.11%
lb-100 conference pre-clinical cancer research

---

Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer
Published: 2023-12-06 (Crawled : 22:00) - biospace.com/
ILMN | $125.36 4.25% 710K |

Health Technology

| 7.6% | O: 1.4% H: 3.94% C: 0.58%
AZN | News | $70.93 1.14% 3.8M |

Health Technology

| 9.56% | O: 0.73% H: 0.06% C: -1.38%
america lung conference test cancer

---

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06 (Crawled : 21:00) - prnewswire.com
ANIX | $3.01 57K |

Health Technology

| -23.41% | O: 2.29% H: 5.63% C: -10.45%
conference vaccine breast positive cancer ongoing study

---

Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program
Published: 2023-12-06 (Crawled : 04:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M |

Health Technology

| -9.73% | O: 0.0% H: 1.07% C: -1.03%
ARVN | $34.56 -0.97% 240K |

Health Technology

| 50.63% | O: 5.35% H: 26.96% C: 24.13%
arv-471 conference breast symposium cancer program

---

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
Published: 2023-12-05 (Crawled : 13:00) - globenewswire.com
BCAB | $2.29 5.05% 390K |

| 59.12% | O: 1.46% H: 8.99% C: 0.72%
america lung conference cancer trial

---

Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
APLM | $0.475 35K |

n/a

| -58.77% | O: -2.63% H: 6.31% C: 0.9%
america lung conference presentation cancer

---

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
ANIX | $3.01 57K |

Health Technology

| -5.64% | O: -0.63% H: 2.52% C: -0.32%
conference cancer research

---

Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
AWH | $3.51 0.29% 3.2K |

Health Technology

| -34.82% | O: -0.28% H: 0.0% C: -6.82%
conference test health cancer research aspira

---

Nuvectis Pharma Announces Upcoming Poster Presentation for NXP800 at the 2023 AACR Special Conference on Endometrial Cancer
Published: 2023-10-24 (Crawled : 12:00) - globenewswire.com
NVCT | $6.85 -3.52% 11K |

| -21.11% | O: 0.0% H: 9.78% C: 0.33%
nxp800 pharma conference presentation cancer

---

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer
Published: 2023-10-23 (Crawled : 12:30) - globenewswire.com
QLGN | $0.2953 8.6K |

Health Technology

| -64.48% | O: 1.65% H: 0.0% C: -6.23%
breast cancer platform

---

BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences
Published: 2023-10-18 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K |

Professional, Scientific, and T...

| -51.58% | O: -1.23% H: 1.42% C: -4.09%
breast cancer immunotherapy

---

Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
XAIR | $1.22 0.83% 170K |

Technology Services

| -45.98% | O: 2.68% H: 0.43% C: -2.61%
conference beyond positive cancer international preclinical therapeutics therapy molecular

---

Acrivon Therapeutics Presents Data Demonstrating Capabilities of its AP3 Platform and ACR-368 OncoSignature Assay for Patient Responder Identification at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
ACRV | $9.995 5.1% 170K |

| 56.93% | O: -1.32% H: 6.1% C: -3.68%
acr-368 conference cancer international therapeutics oncosignature molecular platform

---

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
NCNA | $3.99 34K |

Health Technology

| 495.61% | O: 7.52% H: 2.73% C: -18.38%
nuc-7738 conference cancer international therapeutics molecular

---

Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-14 (Crawled : 20:20) - globenewswire.com
CHRS | $2.225 2.06% 510K |

Health Technology

| Email alert Add to watchlist
conference cancer international therapeutics molecular

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.56 162.07% 21M |

AGBA | $2.74 119.2% 52M |

Finance

CZOO | $9.07 81.76% 22M |

EDBL | News | $6.56 74.47% 1.8M |

OPRT | News | $3.37 49.78% 8.9M |

Finance

MTC | $2.21 41.67% 5.6M |

Technology Services

VNRX | $0.7945 32.42% 3.1M |

Health Technology

MLEC | $1.81 29.29% 2.8M |

n/a

BTCM | $3.45 27.78% 640K |

Arts, Entertainment, and Recrea...

PALI | $6.29 27.59% 22M |

Manufacturing

---

Your saved searches

---